Pfizer Pulls Back On European Viagra Switch As Questions Linger
This article was originally published in The Tan Sheet
Executive Summary
Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20